Who we are
Meet our team.
We have assembled a team of experienced scientists and industry pioneers, including cancer and diagnostic experts and accomplished company builders who are passionate about changing the outlook of a cancer diagnosis.
Our investors include Third Rock Ventures, Section 32, Casdin Capital, Biomatics Capital, BlueCross BlueShield Venture Partners, Invus and others – leading investors in the fields of cancer diagnosis and treatment.